Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Research team led by Dr. Linda Wastila aims to understand how a nationwide effort to reduce the use of antipsychotic medications in long-term care facilities has impacted those facilities’ use of other medications and patient health outcomes.

Bruce Yu, PhD, to lead investigation of novel, inexpensive method to detect protein aggregation in biopharmaceutical drugs.

Sheila Weiss, PhD, concludes successful career in academia and embarks on new opportunity in health services industry.